文献速递慢性肾脏病

退伍军人糖尿病合并CKD的肾脏病诊疗机构间差异

Facility-Level Variations in Kidney Disease Care among Veterans with Diabetes and CKD.
PubMed 文献 · Clin J Am Soc Nephrol · 2018-11-29

该研究纳入281,223名在退伍军人事务部130家机构接受诊疗的糖尿病合并CKD(eGFR 15-59 ml/min per 1.73 m2)患者,评估指南推荐核心措施的执行比例及机构间差异。结果显示,白蛋白尿/蛋白尿检测、血压达标及全部指标达标的比例偏低,且机构间差异显著(中位率比最高达5.2)。

要点

  • 糖尿病合并CKD患者中,尿白蛋白/蛋白检测及全部指标达标率低,机构间差异大。
  • eGFR 30-59 ml/min per 1.73 m2者中,仅37%检测尿白蛋白/蛋白,13%达到全部指标。
  • 调整后中位率比显示,尿白蛋白/蛋白检测和肾脏科转诊的机构间差异最为显著。

核心结论

  • 糖尿病合并CKD患者中,实验室检测开具和肾脏科转诊安排仍不理想,且机构间存在显著差异。

研究设计与样本

  • 回顾性队列研究,纳入281,223名在退伍军人事务部130家机构接受诊疗的糖尿病合并CKD患者(eGFR 15-59 ml/min per 1.73 m2,间隔90天两次测量)。

主要发现

  • eGFR 30-59 ml/min per 1.73 m2者中,各机构推荐核心措施执行比例中位数(四分位距)为:尿白蛋白/肌酐比值或尿蛋白/肌酐比值37%(22%-47%),血红蛋白检测74%(72%-79%),ACEI/ARB处方66%(62%-69%),他汀处方85%(74%-87%),血压<140/90 mm Hg达标47%(42%-53%),全部指标达标13%(7%-16%)。
  • 调整后中位率比(95%CI)分别为:尿白蛋白/肌酐比值或尿蛋白/肌酐比值5.2(4.1-6.4),血红蛋白检测2.4(2.1-2.6),ACEI/ARB处方1.3(1.2-1.3),他汀处方1.2(1.2-1.3),血压达标1.4(1.3-1.4),肾脏科转诊4.1(3.3-5.0)。
  • 限制于eGFR 15-29 ml/min per 1.73 m2者的分析中,中位率比结果定性相似。

关键数值与推荐

  • 中位率比<1为无变异,>1.2为机构间存在实质性变异。
  • 研究评估的核心措施包括:尿白蛋白/肌酐比值或尿蛋白/肌酐比值检测、血红蛋白检测、他汀处方、ACEI/ARB处方、血压<140/90 mm Hg达标、肾脏科转诊(仅eGFR<30 ml/min per 1.73 m2者)。

临床怎么用

  • 应关注糖尿病合并CKD患者中尿白蛋白/蛋白检测和肾脏科转诊的执行情况,减少机构间差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Facility-level variation has been reported among veterans receiving care for various diseases. We studied the frequency and facility-level variations of guideline-recommended practices in patients with diabetes and CKD. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Patients with diabetes and concomitant CKD (eGFR 15-59 ml/min per 1.73 m2, measured twice, 90 days apart) receiving care in 130 facilities across the Veterans Affairs Health Care System were included (n=281,223). We studied the proportions of patients (facility-level) receiving recommended core measures and facility-level variations of these study outcomes using median rate ratios, adjusting for various patient and provider-level factors. Median rate ratio quantifies the degree to which care may vary for similar patients receiving care at two randomly chosen facilities, with <1 being no variation and >1.2 as substantial variation between the facilities. Study outcomes included measurement of urine albumin-to-creatinine ratio/urine protein-to-creatinine ratio and blood hemoglobin concentration, prescription of statins and angiotensin-converting enzyme inhibitors/angiotensin receptor blockers, BP<140/90 mm Hg, and referral to a Veterans Affairs nephrologist (only for those with eGFR<30 ml/min per 1.73 m2). RESULTS: Among those with eGFR 30-59 ml/min per 1.73 m2, proportion of patients receiving recommended core measures (median and interquartile range across facilities) were 37% (22%-47%) for urine albumin-to-creatinine ratio/urine protein-to-creatinine ratio, 74% (72%-79%) for hemoglobin measurement, 66% (62%-69%) for angiotensin-converting enzyme inhibitor/angiotensin receptor blocker prescription, 85% (74%-87%) for statin prescription, 47% (42%-53%) for achieving BP<140/90 mm Hg, and 13% (7%-16%) for meeting all outcome measures. Adjusted median rate ratios (95% confidence intervals) were 5.2 (4.1 to 6.4), 2.4 (2.1 to 2.6), 1.3 (1.2 to 1.3), 1.2 (1.2 to 1.3), 1.4 (1.3 to 1.4), and 4.1 (3.3 to 5.0), respectively. Median rate ratios were qualitatively similar in an analysis restricted to those with eGFR 15-29 ml/min per 1.73 m2. CONCLUSIONS: Among patients with diabetes and CKD, at facility-level, ordering of laboratory tests, and scheduling of nephrology referrals in eligible patients remains suboptimal, with substantial variations across facilities.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Navaneethan SD, Akeroyd JM, Ramsey D, et al. Facility-Level Variations in Kidney Disease Care among Veterans with Diabetes and CKD. Clin J Am Soc Nephrol. 2018. PMID: 30498000. doi:10.2215/CJN.03830318

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。